Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 01, 2023

Switching From Natalizumab Administration at the Day Hospital to Administration at Home

Multiple Sclerosis and Related Disorders


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis and Related Disorders
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35)
Mult Scler Relat Disord 2023 Mar 23;73(xx)104657, S Lamy, D Veillard, H Doyen, A Kerbrat, L Michel, E Chretien, A Ousmen, G Edan, E Le Page

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading